Kymera Therapeutics Claimed Company

Kymera Therapeutics is a clinical stage biopharmaceutical company pioneering a transformative new modality, “targeted protein degradation” (TPD), with the ability to pursue targets long considered undruggable and to treat disease in entirely new ways. Our team has developed a proprietary drug discovery engine, Pegasus, to enable the design of highly selective, small molecule protein degraders with potent activity against a broad range of disease indications. We are committed to selecting targets with the broadest possible impact across multiple disease indications with high unmet medical need to realize the full potential of TPD. Kymera is led by an expert team of dedicated scientists and drug hunters, with decades of experience in the foundational areas of targeted protein degradation and drug development. read more

EMPLOYEE PARTICIPANTS: 12

TOTAL RATINGS: 194

CEO: Nello Mainolfi, PhD

HR or Marketing? Claim Your Free Employer Account

Kymera Therapeutics Awards

Kymera Therapeutics has not won any awards as of yet. However, based on 194 ratings and 12 participants, employees at Kymera Therapeutics are less satisfied with their work experience. The overall culture score, 73/100 or C+, incorporates employee ratings based on their feedback on the Team, Outlook, Meetings and more. Also, Kymera Therapeutics ranks in the top 50% of similar size companies and top 40% of companies on Comparably

Awards

Comparably Awards are provided yearly to top performing company cultures based on real feedback from their employees.

Kymera Therapeutics hasn't won any awards yet.

Top

50%

Kymera Therapeutics currently ranks in the Top 50% of similarly sized companies on Comparably

Top

40%

Kymera Therapeutics currently ranks in the Top 40% of nearby companies

Kymera Therapeutics does not have enough ratings to rank against competitors.

Help Your Company Win 2025 Awards

Anonymously rate your experience & help make Kymera Therapeutics a better place to work.